
Northwest Biotherapeutics Eyes Saudi Market in SPIMACO Partnership
Northwest Biotherapeutics has signed a non-binding memorandum of understanding with Saudi Pharmaceutical Industries and Medical Appliance Company to bring its DCVax-L personalized immune therapy to the Middle East. The agreement marks a strategic push to introduce the company’s glioblastoma treatment into the Saudi healthcare market.























